+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of total vs partial androgen blockade in the treatment of advanced prostatic cancer preliminary results of a multicenter prospective and randomized study



Evaluation of total vs partial androgen blockade in the treatment of advanced prostatic cancer preliminary results of a multicenter prospective and randomized study



The Journal of Urology 137(6): 255A




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 028290024

Download citation: RISBibTeXText

DOI: 10.1016/s0022-5347(17)75756-4


Related references

Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer: results of a prospective randomized multicenter trial. Clinical Prostate Cancer 1(3): 163-171, 2002

Intermittent versus continuous total androgen blockade in the treatment of patients with advanced hormone-naive prostate cancer Results of a randomized prospective multicenter clinical trial. Journal of Urology 167(4 Suppl.): 175, 2002

Evaluation of total versus partial androgen blockade in the treatment of advanced prostatic cancer. Urologia Internationalis 43(4): 193-197, 1988

A prospective randomized multicenter study of chlormadinone acetate versus flutamide in total androgen blockade for prostate cancer. Japanese Journal of Clinical Oncology 30(9): 389-396, 2000

Complete androgen blockade versus chemical castration in advanced prostatic cancer: Analysis of an Italian multicenter study. Urologia Internationalis 60(Suppl. 1): 18-24, 1998

Evaluation of quality of life in patients with previously untreated advanced prostate cancer receiving maximum androgen blockade therapy or LHRHa monotherapy: a multicenter, randomized, double-blind, comparative study. Journal of Cancer Research and Clinical Oncology 134(12): 1385-1396, 2008

Evaluation of the concepts of total and partial androgen blockade in treatment of patients with advanced carcinoma of the prostate. Proceedings of the American Association for Cancer Research Annual Meeting 30: 295, 1989

Total androgen blockade with Zoladex plus flutamide vs. Zoladex alone in advanced prostatic carcinoma: interim report of a multicenter, double-blind, placebo-controlled study. European Urology 18(Suppl. 3): 45-47, 1990

Comparative results of the variations in intra prostatic androgen levels and androgen receptors following pulpectomy with or without an anti androgen flutamide in the treatment of advanced prostatic cancer. Murphy, G P , Et Al (Ed ) Progress in Clinical And Biological Research, Vol 243a Prostate Cancer, Part A: Research, Endocrine Treatment, And Histopathology; Second International Symposium, Paris, France, June 16-18, 1986 Xl+586p Alan R Liss, Inc : New York, New York, Usa Illus 77-78, 1987

Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group. Urology 50(3): 330-336, 1997

PSA evolution: a prognostic factor during treatment of advanced prostatic carcinoma with total androgen blockade. Data from a Belgian multicentric study of 546 patients. Acta Urologica Belgica 65(3): 63-71, 1997

Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study. Urology 64(2): 341-345, 2004

Total androgen blockade in the treatment of advanced prostatic carcinoma final report of a double blind placebo controlled study using zoladex and flutamide. Journal of Urology 145(4 Suppl.): 426A, 1991

Is androgen receptor gene amplification in recurrent prostate cancer a predictor of favourable second-line responsiveness to maximal androgen blockade? Preliminary results from a three month prospective follow-up study. Scandinavian Journal of Urology and Nephrology Suppl. 0(186): 11, 1997

Randomized prospective evaluation of the effect of either total androgen blockade or a Serenoa repens extract on cell proliferation and apoptosis in human localized prostate cancer. European Urology Suppl.s 3(2): 148, 2004